Diagnostic criteria for idiopathic pulmonary fibrosis: a Fleischner Society White Paper

DA Lynch, N Sverzellati, WD Travis… - The Lancet respiratory …, 2018 - thelancet.com
This Review provides an updated approach to the diagnosis of idiopathic pulmonary fibrosis
(IPF), based on a systematic search of the medical literature and the expert opinion of …

Pulmonary alveolar proteinosis in adults: pathophysiology and clinical approach

A Kumar, B Abdelmalak, Y Inoue… - The Lancet Respiratory …, 2018 - thelancet.com
Pulmonary alveolar proteinosis (PAP) is a diffuse lung disease that results from the
accumulation of lipoproteinaceous material in the alveoli and alveolar macrophages due to …

[HTML][HTML] Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis

L Richeldi, RM Du Bois, G Raghu… - … England Journal of …, 2014 - Mass Medical Soc
Background Nintedanib (formerly known as BIBF 1120) is an intracellular inhibitor that
targets multiple tyrosine kinases. A phase 2 trial suggested that treatment with 150 mg of …

An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial …

WD Travis, U Costabel, DM Hansell… - American journal of …, 2013 - atsjournals.org
Background: In 2002 the American Thoracic Society/European Respiratory Society
(ATS/ERS) classification of idiopathic interstitial pneumonias (IIPs) defined seven specific …

Diagnosis of idiopathic pulmonary fibrosis. An official ATS/ERS/JRS/ALAT clinical practice guideline

G Raghu, M Remy-Jardin, JL Myers… - American journal of …, 2018 - atsjournals.org
Background: This document provides clinical recommendations for the diagnosis of
idiopathic pulmonary fibrosis (IPF). It represents a collaborative effort between the American …

Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: an official ATS/ERS/JRS/ALAT clinical practice guideline

G Raghu, M Remy-Jardin, L Richeldi… - American Journal of …, 2022 - atsjournals.org
Background: This American Thoracic Society, European Respiratory Society, Japanese
Respiratory Society, and Asociación Latinoamericana de Tórax guideline updates prior …

[HTML][HTML] Diagnostic and prognostic biomarkers for chronic fibrosing interstitial lung diseases with a progressive phenotype

Y Inoue, RJ Kaner, J Guiot, TM Maher, S Tomassetti… - Chest, 2020 - Elsevier
Biomarkers have the potential to become central to the clinical evaluation and monitoring of
patients with chronic fibrosing interstitial lung diseases (ILDs) with a progressive phenotype …

The role of chest imaging in patient management during the COVID-19 pandemic: a multinational consensus statement from the Fleischner Society

GD Rubin, CJ Ryerson, LB Haramati, N Sverzellati… - Radiology, 2020 - pubs.rsna.org
With more than 900 000 confirmed cases worldwide and nearly 50 000 deaths during the
first 3 months of 2020, the coronavirus disease 2019 (COVID-19) pandemic has emerged as …

[HTML][HTML] Nintedanib in progressive fibrosing interstitial lung diseases

KR Flaherty, AU Wells, V Cottin… - … England Journal of …, 2019 - Mass Medical Soc
Background Preclinical data have suggested that nintedanib, an intracellular inhibitor of
tyrosine kinases, inhibits processes involved in the progression of lung fibrosis. Although the …

Diagnosis of hypersensitivity pneumonitis in adults: an official ATS/JRS/ALAT clinical practice guideline

G Raghu, M Remy-Jardin, CJ Ryerson… - American journal of …, 2020 - atsjournals.org
Background: This guideline addresses the diagnosis of hypersensitivity pneumonitis (HP). It
represents a collaborative effort among the American Thoracic Society, Japanese …